Search
for
Sort by
Research 211–240 of 230
- Granuloma Annulare Mimicking Alopecia Mucinosa in a Child: An Atypical Presentation
- Epigenetic Mechanisms, Assessment and Therapeutics of Epidermal Stem Cells in Skin Aging
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- Trigonelline nanocrystal-based topical creams for the treatment of hair loss
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Treatments for alopecia areata: a network meta-analysis
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Hair Disorders in Autoimmune Diseases
- 1,314
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Cells to Surgery Quiz: April 2020
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Resolution of refractory generalized granuloma annulare after treatment with alitretinoin
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review
- Therapeutic potential of Hibiscusrosa sinensis - A Review
- A Review on Herbal Hair Serum
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders
- Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- Apremilast is efficacious in refractory alopecia areata
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials